Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Cemic

Ciudad Autonoma de Buenos Aires, Buenos Aires, ArgentinaNot linked to an institution yet

2running trials
1closed trial
0trials confirmed by the site in the last 60 days
–languages not stated

No trial has been confirmed here yet.

Running trials

Active, not recruiting
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
NCT07005128· Phase 3· Source
Active, not recruiting
Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer
NCT05740566· Phase 3· Source

Researchers

No researcher is linked here yet.

Closed trials

Recruiting
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
NCT06252649· Phase 3· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error